Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant. - Berk,P.; Hoogerbrugge,N.; Stolk,R.P.; Bootsma,A.H.; Jansen,H. (Diabetes Care, 2003)